Many commensal bacteria and opportunistic pathogens scavenge heme from their environment. 19
non-invasive disease, such as recurrent otitis media (Ngo et al., 2016) and exacerbations of chronic 41 obstructive pulmonary disease (Sethi and Murphy, 2008) . 42
43
The management of NTHi infections is becoming increasingly difficult. The intrinsic heterogeneity 44 of NTHi has hampered vaccine development, and despite significant effort, an effective vaccine is 45 not currently available (Cerquetti and Giufre, 2016) . There has been an increase in both the 46 incidence and spectrum of antimicrobial resistance in NTHi (Tristram et al., 2007) and the 47 development of new antibiotics for NTHi has recently been listed as a priority by the World Health 48
Organisation, emphasising the need for new approaches to the prevention and management. 49
50
As an alternative to antibiotics, bacteriocin-producing strains of upper respiratory tract commensal 51 streptococci have been commercialized as probiotics to prevent and treat S. pyogenes infections (Di 52 Pierro et al., 2016) , and, more recently, bacteriocin-producing strains of Staphylococcus 53 lugdunensis were shown to be associated with reduced nasal carriage of S. aureus (Zipperer et al., 54 insertional inactivation with a kanamycin resistance cassette. Media recovered from cultures of the 114 knockout strain displayed no inhibitory activity against NTHi ( Supplementary Fig. 3 ). Growth 115 medium recovered from BW1 or the BW1 hemophilin gene knockout contained similar protein 116 content overall, as judged by chromatographic separations and silver staining, with the notable 117 exception that the hemophilin protein band was absent from the knockout samples (Supplementary 118 Fig. 3 ). In summary, these results show that hemophilin is the NTHi-inhibitory protein from H. 119 haemolyticus isolates BW1 and RHH122. 120 121 Hemophilin is a heme binding protein 122
The UV-visible absorption spectrum of the hemophilin had strong absorption bands at 415 nm, 540 123 nm and 575 nm, which are characteristic of the Soret and α/β bands of a hemoprotein ( Fig. 2A, red  124 trace). The presence of non-covalently bound heme b was confirmed by RP-HPLC and mass 125 spectrometry ( Fig. 2B ). Apo hemophilin (hemophilin with the heme group removed) was able to 126 bind reduced ferrous heme or oxidised ferric heme, and the reconstituted holo proteins were 127 competent to bind to a variety of small ligands that are specific for ferrous (O 2 , CO; Supplementary 128 Supplementary Fig. 5 ) hemes. The UV-visible spectrum of apo 129 hemophilin ( Fig. 2A , black trace) reconstituted with ferrous heme and O 2 ( Fig. 2A, green) is 130 essentially identical to that of hemophilin purified from E. coli as the holo protein ( Fig. 2A, red) , 131
suggesting that the E. coli derived protein is the O 2 -bound form. 132
133
The holo and apo hemophilin fractions gave very similar far-UV CD spectra, with maxima at ~200 134 nm and minima between 220-230 nm, indicating a mixture of β-sheet and α-helical secondary 135 structure elements, and no major change in secondary structure upon heme binding (Fig. 2C ). This 136 is unlike hemoglobins or heme-binding enzymes, which typically undergo at least partial 137 denaturation in the absence of the heme cofactor, and is more similar to the apo state characteristics 138 of transient heme binding proteins, such as heme transport proteins, which essentially have folded 139 apo protein structures (Smith et al., 2010) . In addition, the hemophilin apo protein displayed NTHi-140 inhibitory activity that was typically 3-4 fold higher than that of the holo protein (Fig. 2D ). The 141 structure and activity of apo hemophilin suggest that reversible binding to heme is likely to be a 142 function of this protein. 
152
Hemophilin has a novel heme binding structure 153
Holo hemophilin was crystallized and the structure determined by x-ray diffraction to a resolution 154 of 1.6 Å ( Supplementary Table 2 ). Initial phases were obtained by single wavelength anomalous 155 diffraction (SAD) from the heme iron, above the absorption K-edge. All residues of hemophilin 156 (23-272) are visible in the electron density. The hemophilin structure comprises an N-terminal 157 region with mixed α/β secondary structure ( Fig. 3 , blue-green) that binds a single heme molecule 158 ( Fig. 3A , grey sticks and orange sphere), and a C-terminal 8-stranded β-barrel ( Fig. 3 , yellow-red). 159
Helix and loop insertions between the β-3 and β-4 strands, and between the β-5 and β-6 strands, 160 cover both faces of the porphyrin ring and provide the majority of protein-heme contacts. The DALI 161 server shows that several bacterial proteins have structural similarity to hemophilin (Supplementary 162 Fig. 6 ). Notably, all are cell-surface proteins with ligand binding functions ( Supplementary Fig. 7) , 163 found in Neisseriaceae and some members of the Pasteurellaceae, but none have heme binding 164 function or structural similarity within the hemophilin heme-binding site. No heme-binding domain 165 with similarity to hemophilin could be detected by structure-or sequence-based searches. 
172
In the hemophilin crystal structure, a heme molecule and a small exogenous heme ligand are clearly 173 visible in electron difference density OMIT maps ( Fig. 4A ; electron difference density maps from 174 the early stages of structure refinement using a model comprising only the hemophilin polypeptide 175 are shown in Supplementary Fig. 8 ). Electron density and an anomalous diffraction peak at the 176 ligand position indicated a single heavy atom, which was modelled as a chloride ion (Fig. 4A ). The 177 recombinant hemophilin protein used for crystallization was predominantly ferrous O 2 complex but 178 contained some ferric protein ( Supplementary Fig. 9 ), and the crystallization conditions (pH 4.5) 179 favoured further heme oxidation (Supplmentary Fig. 10 ), which would allow chloride binding 180 (Supplementary Figure 11 shows that ferric hemophilin has a K d of ~3 mM for chloride binding; Fig. 12 ; Supplementary Table 3) . hemoglobins. His119 and all its caging residues, bar Ala69, lie on the protein loop between β 193 strands 5 and 6 that extends across one face of the heme group (Fig. 4C ); a conformational change 194 in this loop could, therefore, be a possible mechanism to achieve heme entry and exit-solution 195 state studies will be required to address this. The heme Fe atom sits in the plane of the porphyrin- Supplementary Fig. 12 ). The heme is oriented with the iron atom and porphyrin 202 ring almost completely buried (solvent accessible non-polar area of 47 Å 2 , compared to 688 Å 2 for 203 free heme) and the ionisable propionate groups pointing out into solvent ( Fig. 4D) . 
217
To investigate whether the heme binding function of hemophilin is required for NTHi-inhibitory 218 activity, we made a His to Gln substitution of the heme-coordinating His119 (H119Q). Unlike wild-219 type hemophilin, the H119Q mutant protein purified from E. coli without a heme cofactor, 220
indicating a large reduction in heme binding affinity ( Supplementary Fig. 13 ). Mixing heme with 221 the H119Q mutant gave a spectrum with peaks at 404, 485 and 602 nm, similar to spectra of ferric 222 heme:protein complexes without an Fe-coordinating side chain (Gao et al., 2018) , suggesting that 223 the H119Q mutant binds heme, but probably does not form an axial bond to the iron. The H119Q 224 mutant was not inhibitory to NTHi at the concentrations tested ( Fig. 4E and Supplementary Fig. 13 ), 225
indicating that heme coordination through H119 contributes substantially to NTHi inhibition. 226 227
Hemophilin sequesters a pool of heme and makes it available to H. haemolyticus but not to the 228 related species NTHi 229
H. haemolyticus is unable to synthesise porphyrin and must acquire heme from the environment 230 (Norskov-Lauritsen, 2014). Therefore, we hypothesised that hemophilin might function as part of a 231 heme uptake pathway. To investigate this idea, we compared the growth of BW1 and the 232 hemophilin knockout strain under different heme supplementation regimes. BW1 that was 233 propogated in heme-replete TSB media, continued to grow when heme supplementation was 234 withdrawn ( After a 14-hour conditioning period in heme-deficient TSB media, BW1 now showed a strong 237 dependence on heme supplementation for growth ( Fig. 5B and Supplementary Fig. 14) . In contrast, 238 after conditioning in heme-replete TSB, the hemophilin knockout strain showed poor growth at all 239 heme concentrations (Fig. 5C ), and this was exacerbated after heme starvation ( Fig. 5D ), whereas 240 the strain could be propogated for long periods on blood-supplemented media (not shown). These 241 results suggest that the hemophilin knockout strain has a reduced capacity to utilise free heme. 242
243
To test directly if hemophilin can deliver heme to H. haemolyticus, we grew cultures supplemented 244 with heme or holo hemophilin at matching final molar concentrations. When BW1 was initially 245 cultured with growth-limiting concentrations of heme (0.6 µg mL -1 ), subsequent addition of holo 246 hemophilin resulted in approximately 3-fold increase in culture density at 20 hours (Supplementary 247 Fig. 15 ). This growth was the same as growth on an equivalent amount of free heme 248 ( Supplementary Fig. 15 ), suggesting that hemophilin-bound heme was readily available to BW1. In 249 contrast, the addition of holo hemophilin to NTHi caused a decrease in growth (approximately 2-250 fold decrease in cell density at 20 hours; Supplmentary Fig. 15 ). Moreover, we found that the 251 inhibition of NTHi in the agar well diffusion assay was overcome by addition of excess heme 252 ( Supplementary Fig. 16 ). Together, these results suggest that hemophilin binds heme in a form that 253 can be utilised by H. haemolyticus BW1, but is not accessible to NTHi, and that inhibition of NTHi 254 occurs by heme starvation. 
262

Distribution of hemophilin across H. haemolyticus strains 263
To gain insight into the broader biological significance of hemophilin, we searched the public 264 sequence databases. From 46 complete or draft H. haemolyticus genomes available in Genbank, 30 265 genomes contained an ORF with 67-100% nucleotide sequence identity to BW1 hemophilin 266 ( Supplementary Table 4 ). In addition, 18 H. influenzae genomes (from a total of 700 genome 267 assemblies), 3 H. quentini genomes (from a total of 3 assemblies), 1 H. parainfluenzae genome 268 (from a total of 40 assemblies) encoded an ORF with similarity to BW1 hemophilin. In each case, 269 the hemophilin gene was immediately downstream of a predicted TonB dependent transporter 270
( Supplementary Table 4 ). Across the 25 unique hemophilin-like sequences encoded by all genomes, 271 amino acid differences overwhelmingly mapped to surface exposed sites and surface loops on the 272 hemophilin structure ( Supplementary Fig. 17 Table 5 ). By real-time PCR, 15 isolates were positive; 286 this primer set would theoretically have produced an amplicon for 7 of the 46 public H. 287 haemolyticus genomes; the same 15% hit rate. We found 6 isolates, including BW1 and RHH122, 288
with ORFs that were 100% identical, and found that the NTHi-inhibitory activity recovered from 289 these isolates varied considerably ( Supplementary Table 5 ). This suggests that high-level 290 production of hemophilin is an unsual feature of BW1/RHH122 and emphasises the importance of 291 understanding how hemophilin expression is regulated, in addition to the effects of sequence 292 variation within the hemophilin protein. 
Hemophilin is a previously undescribed hemophore in H. haemolyticus 297
In a screen for potential probiotic strains of H. haemolyticus that produce inhibitors of NTHi, we 298 identified hemophilin, a small soluble heme binding protein that is secreted at high levels by two H. 299 haemolyticus isolates, BW1 and RHH122. Our data suggest that hemophilin plays a positive role in 300 heme acquisition in H. haemolyticus, and that the inhibition of NTHi, a pathogenic microorganism 301 that shares a similar ecological niche in the upper respiratory tract of humans, is likely to involve 302 competition for nutrient heme. Table 4 ); in each pathway the initial heme binding step is performed by a 308 membrane anchored protein or TonB-dependent outer membrane heme transporter. By comparison, 309
hemophilin represents a previously unidentified mechanism in Haemophilus spp-that is, secretion 310 of a diffusible heme binding protein (a hemophore) into the surrounding environment. Hemophores 
Proteins with structural similarity to hemophilin bind diverse ligands 353
The small group of proteins that share structural similarity with hemophilin includes hemoglobin- meander topology with a shear value of 8) together with hydrophobic residues packed in the barrel 362 core seems to occur only in this group of bacterial proteins ( Supplementary Fig. 6 ). Table 4 ). Molecular modelling using the PHYRE and I-371 TASSER web servers confidently predicts that the putative hemophilin receptor has a 22-strand β-372 barrel and plug structure with similarity to TbpA and HasR ( Supplementary Fig. 18) . Table 4 ). In addition, 98% of strains have at least 1 386 gene encoding a transporter for heme uptake from hemoglobin/haptoglobin (hgpA, hgpB, hgpC). 387
Thus, the majority of these H. influenzae strains have highly redundant pathways for accessing 388 heme from a variety of host sources. 
By scavenging heme, hemophilin might be a mechanism of exploitative competition between 401
Haemophilus species 402
We undertook our initial search for strains of H. haemolyticus that could inhibit NTHi with the goal 403 of developing respiratory tract probiotics. The paradigm on which we based this search was that 404 some bacterial strains produce bacteriocins to kill other species that share the same ecological niche 405 (Ghequire et al., 2017; White et al., 2017) . The fact that we identified hemophilin, a putative 406 hemophore, suggests that sequestering heme might be another mechanism for bacteria to inhibit 
Materials and Methods
424
Bacterial collection and culture 425
The origin and method of identification of the bacterial strains has been described previously 426 (Latham et al., 2017) . For revival, subculturing, and enumeration of Haemophilus spp., chocolate 427 agar (CA) was used and incubated for 18-24 h at 35°C in an atmosphere of 5-10% CO 2 . Isolates 428 were stored at -80°C in 10% w/v sterile skim milk media (SMM). 429
Preparation of heme solutions 430
Solutions (1-5 mg mL -1 ) of ferriprotoporphyrin IX were prepared fresh by dissolution in 0.1 M 431 sodium hydroxide of either bovine hemin chloride (ferriprotporphyrin IX chloride, Frontier 432 Scientific), or porcine hematin (ferriprotoporphyrin IX hydroxide, Sigma-Aldrich) solid, as 433 specified in sections of Materials and Methods. Unless otherwise specified, the term heme is used 434 generically throughout the main text for simplicity, irrespective of the source or oxidation state. 435 436
Agar well diffusion assay 437
The agar well diffusion assay was performed as described previously (Latham et al., 2017) , with the 438 following clarifications. Solid media consisted of 18.5 g L -1 brain heart infusion (Oxoid) solidified 439 with 7.5 g L -1 Bacteriological Agar (Oxoid), autoclaved at 121°C for 30 min, cooled to 50°C, then 440 supplemented with 1% (v/v) resuspended Vitox® (Oxoid), along with 7.5 mg L -1 each of NAD and 441 hematin (Oxoid); these media components are at half the normal concentration typically used for 442 the culture of Haemophilus influenzae. 10 mL of agar was dispensed to a 90-mm Petri dish. 443
Indicator strains (NTHi strain NCTC 4560 or NCTC 11315) were prepared by growing for 6-12 h 444 on CA then suspended in Dulbecco's phosphate buffered saline (DPBS, Gibco) to an absorbance of 445 1.0, diluting 10-fold with SMM and stored as 100-µL aliquots at -80°C. Thawed aliquots were 446 diluted 100-fold in DPBS and mixed with 5 mL of molten overlay media at a dose predetermined to 447 produce a dense lawn of colonies and immediately poured onto a petri dish of base media. 5-mm 448 diameter circular holes were cut in the agar using a sterile stainless steel cork borer to accept 20-25 449 µL of test solutions. Plates were left open in a biological safety cabinet for one hour until wells 450 were free of liquid then incubated for 18-24 h at 35°C in a humidified atmosphere containing 5% 451 CO 2 and the annular radius of cleared zones was recorded. Clearing zone size was affected by 452 media age (older media giving larger the zone sizes), such that treatments were only compared 453 within the same plate. 454 455
Production of native hemophilin 456
Media for hemophilin production was cold filterable tryptone soya broth (TSB; Oxoid) made to the 457 manufacturer specifications and sterilised by filtration through membrane with a pore size of 0.2 458 µm, then supplemented with HTM supplement (Oxoid) and Vitox® (Oxoid) according to 459 manufacturers specification. Cultures of BW1 or RHH122 were grown on CA for 12-16 hours, 460 suspended in pre-warmed (37°C) broth in a baffled shakeflask to an absorbance of 0.05 (OD600), 461 then incubated with 200 RPM agitation at 37°C for 24 hours. Culture broths were clarified by 462 centrifugation at 7000 × g for 30 minutes. Hemophilin activity was enriched by ammonium sulfate 463 precipitation at 4°C, with the 50-70% saturation cut collected and redissolved in a volume of PBS 464 equal to 1/20th of the initial culture broth volume then dialysed using a 3500-Da molecular weight 465 cut off (MWCO) dialysis membrane (Thermofisher) for 24 hours at 4°C against 50 mM Tris-HCl, 466 pH 7.5. Following concentration by ultrafiltration with a 10-kDa MWCO centrifugal filter unit 467 (Merck-Millipore) the samples were separated over a Superose 12 HR 10/300 GL column (GE 468
Healthcare) with a bed volume of 24 mL, in 0.15 M sodium phosphate buffer, pH 7.0. Fractions 469 with peak acitvity were applied to a C 4 reversed-phase HPLC column (Symmetry300; Waters 470
Corporation) that was developed with a linear gradient of 5-95% CH 3 CN, 95-5% H 2 O, 0.1% 471 trifluoroacetic acid. Fractions were collected manually and lyophilised, then resuspended in 472 aqueous buffer of choice. 473
474
RP-HPLC and mass spectrometry 475
RP-HPLC fractions from the H. haemolyticus isolates BW1 or RHH122 that had peak hemophilin 476 activity, or time/volume matched samples from control isolates, were subject to trypsin digestion in 477 batch, or were processed further by Tris-tricine SDS-PAGE, silver staining and in-gel trypsin 478 digestion of individual stained bands, as specified in Results. Silver stain was removed using 30 479 mM potassium ferricyanide and 100 mM sodium thiosulfate (1:1 mix) and gel pieces were dried by 480 vacuum centrifugation. In-gel trypsin digestion was performed using proteomic grade trypsin 481 (Sigma) as previously described (Wilson et al., 2008) . For trypsin digest of HPLC fractions, 482 samples were precipitated in 9 volumes of ethanol, then reduced, alkylated and digested in 100 mM 483 ammonium bicarbonate buffer as previously described (Wilson et al., 2008) . Peptide samples were 484 reconstituted in 20 µL HPLC Buffer (2% CH 3 CN, 0.05% trifluoroacetic acid) and analyzed by 485 nanoLC-MS/MS using an Ultimate 3000 RSLCnano HPLC and LTQ-Orbitrap XL fitted with 486 nanospray Flex ion source (ThermoFisher Scientific). Tryptic peptides were loaded at 0.05 mL min -487 1 onto a C 18 20 mm × 75 mm PepMap 100 trapping column then separated on an analytical C 18 150 488 mm × 75 mm PepMap 100 column nano-column Peptides were eluted in a gradient from 98% 489 buffer A (0.01% formic acid in water) to 40% buffer B (0.08% formic acid in 80% CH 3 CN and 490 The concentration of apo hemophilin was determined by spectrophotometry using an extinction 555 coefficient, ε 280 = 25.9 × 10 3 M -1 cm -1 at 280 nm wavelength, calculated from amino acid 556 composition. The concentration of the holo protein was determined using an extinction coefficient, 557 ε 280 = 38.6 ± 3.6 × 10 3 M -1 cm -1 at 280 nm determined from area under the curve analysis of RP-558 HPLC chromatograms of apo and holo hemophilin performed in triplicate. The ~10% error in 559 concentration measurements for the holo protein were below the detection limit in SDS-PAGE 560 comparison of apo and holo samples (e.g., Fig. 2D ). 561
562
BW1 hemophilin Knockout 563
To confirm the role of hemophilin in generating the anti-NTHi activity of strain BW1, an NIS 564 knockout was constructed using insertional inactivation. A partially assembled WGS of H. 565 haemolyticus strain 11P18 (Seq ID: LCTK01000015, contig 00016) was used to acquire sequence 566 flanking the hemophilin ORF for PCR primer design. These PCR primers, NIS-KO-F 567 (gctagacgtgctgatgtt) and NIS-KO-R (tgttgttcttgtcgttgttg) were then used to generate a 1691 bp 568 fragment using genomic DNA from strain BW1 as template. This 1691 bp fragment containing the 569 hemophilin ORF (bp 700-1518) and a unique BspTI site was cloned in to pGEM-T (Promega) 570 according to the manufacturer's instructions. An 1132 bp kanamycin resistance cassette, generated 571 by PCR with BspTI tagged primers Kana-Bsp-F (5'-GCGCCTTAAGTAAACCTGAACCAAA-3') 572
and Kana-Bsp-R (5'-GCGCCTTAAGGTCGTCAGTCATAAA-3') using pLS88 (Genbank L23118) 573 as template, was then sub-cloned into the BspTI site using standard methods. The hemophilin ORF 574 containing the kanamycin cassette was then PCR amplified using NIS-KO-F and NIS-KO-R 575 primers and transformed into strain BW1 using the MIV method (Herriott et al., 1970) . 576
Transformants were selected on CA supplemented with 50 mg L -1 kanamycin and confirmed by 577 sequencing of the hemophilin region. Sequence verified transformants were tested for the NTHi 578 inhibitory phenotype using an ammonium sulfate extract of a broth culture in a well diffusion assay 579 as previously described (Latham et al., 2017) . 580
581
UV-visible spectroscopy 582
UV-visible spectra were recorded on a Jasco V-630 spectrophotometer fitted with a temperature-583 controlled sample holder (Jasco) and a septum sealed spectrosil quartz cuvette with a path length of 584 1.0 cm (Starna, Baulkham Hills, Australia). Samples were prepared at final protein concentration 5-585 7 µM in 0.1 M sodium phosphate, pH 7.0, unless otherwise stated. Solutions of heme were prepared 586 fresh by dissolving hemin chloride (Frontier Scientific) to a concentration of ~1 mM in 0.1 M 587 NaOH; for chloride/fluoride binding experiments, hematin was used in place of hemin chloride. 588
Solutions were filtered through a PVDF membrane with a pore size of 0.45 µm (Millipore) and 589 concentrations were determined spectrophotometrically using an extinction coefficient ε 280 = 58.4 × 590 10 3 M -1 cm -1 in 0.1 M NaOH (Dawson et al., 1969) . Ferrous heme was prepared by dilution of 591 heme into nitrogen-purged buffer with addition of molar excess of sodium dithionite; the formation 592 of ferrous heme was monitored spectrophotometrically. All liquid transfer steps were performed 593 under positive N 2 pressure using a gas-tight syringe (SGE Analytical Science). O 2 and CO adducts 594
